Dr. Khin Win, MD

NPI: 1265720619
Total Payments
$1,970
2023 Payments
$16.73
Companies
6
Transactions
9

Payment Breakdown by Category

Travel$1,468 (74.5%)
Food & Beverage$501.75 (25.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Travel and Lodging $1,468 3 74.5%
Food and Beverage $501.75 6 25.5%

Top Paying Companies

Company Total Records Latest Year
Hoffmann-La Roche Limited $1,103 3 $0 (2018)
Genentech, Inc. $537.37 1 $0 (2020)
AstraZeneca Pharmaceuticals LP $248.39 2 $0 (2017)
Gilead Sciences Inc $39.52 1 $0 (2017)
Daiichi Sankyo Inc. $24.78 1 $0 (2017)
AbbVie Inc. $16.73 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2023 $16.73 1 AbbVie Inc. ($16.73)
2020 $537.37 1 Genentech, Inc. ($537.37)
2018 $1,103 3 Hoffmann-La Roche Limited ($1,103)
2017 $312.69 4 AstraZeneca Pharmaceuticals LP ($248.39)

All Payment Transactions

9 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
03/10/2023 AbbVie Inc. QULIPTA (Drug) Food and Beverage In-kind items and services $16.73 General
Category: NEUROSCIENCE
03/11/2020 Genentech, Inc. Non-Covered Product (Drug) Travel and Lodging In-kind items and services $537.37 General
Category: None
02/23/2018 Hoffmann-La Roche Limited TECENTRIQ (Biological) Travel and Lodging In-kind items and services $801.89 General
Category: BioOncology
02/23/2018 Hoffmann-La Roche Limited TECENTRIQ (Biological) Food and Beverage In-kind items and services $172.33 General
Category: BioOncology
02/23/2018 Hoffmann-La Roche Limited TECENTRIQ (Biological) Travel and Lodging In-kind items and services $129.00 General
Category: BioOncology
08/29/2017 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $123.72 General
Category: Cardiovascular and Metabolism
07/30/2017 Gilead Sciences Inc Vemlidy (Drug) Food and Beverage In-kind items and services $39.52 General
Category: HBV
04/17/2017 Daiichi Sankyo Inc. Movantik (Drug) Food and Beverage In-kind items and services $24.78 General
Category: Opioid Induced Constipation
02/23/2017 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $124.67 General
Category: Cardiovascular and Metabolism

About Dr. Khin Win, MD

Dr. Khin Win, MD is a Clinic/Center healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2011. The National Provider Identifier (NPI) number assigned to this provider is 1265720619.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Khin Win, MD has received a total of $1,970 in payments from pharmaceutical and medical device companies, with $16.73 received in 2023. These payments were reported across 9 transactions from 6 companies. The most common payment nature is "Travel and Lodging" ($1,468).

Practice Information

  • Specialty Clinic/Center
  • Other Specialties General Acute Care Hospital, Internal Medicine
  • Location New York, NY
  • Active Since 07/19/2011
  • Last Updated 01/27/2016
  • Taxonomy Code 261Q00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1265720619

Products in Payments

  • TECENTRIQ (Biological) $1,103
  • Non-Covered Product (Drug) $537.37
  • FARXIGA (Drug) $248.39
  • Vemlidy (Drug) $39.52
  • Movantik (Drug) $24.78
  • QULIPTA (Drug) $16.73

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Clinic/Center Doctors in New York